Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma and biopharma fill-finish machinery.
Pharmaceutical Industry News
CIONIC, the innovative bionic clothing company dedicated to improving mobility with the breakthrough FDA-cleared Cionic Neural Sleeve, was recognized with multiple top awards at the 2023 International Design Excellence Awards (IDEA) by the Industrial Designers Society of America (IDSA), including a gold award for Digital Interaction, and a silver for design in the Medical & Health category.
OZTx, with the aim of social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation), is conducting research and development of regenerative medicine using iPS cell-derived cardiomyocytes and islet cells and supports commercialization of development candidate seeds through collaboration with commercial partnerships and academic institutions.
Pain Insights conducted a patient-centered survey to better understand the needs of patients with recurrent and chronic pain, review pain management needs in potentially vulnerable patient populations across the lifespan, such as Veterans, the elderly, unborn children, and those with genetic diseases, and to present information on potential pain-related initiatives.
Lysando, the leading pioneer in the field of antimicrobial proteins has achieved significant milestones with its cutting-edge Artilysin® technology.
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, unveiled today Vertiva™, the latest release of its patented On-Body Delivery System (OBDS).
Centinel Spine®, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease by providing the most robust and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), will present at the 2023 Castellvi Spine Symposium.
Epinephrine Injection, USP, is indicated for emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine is also indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.
Christopher Martin, a stroke survivor, has made a remarkable recovery following his participation in the Neurologic Stem Cell Treatment Study. The consequences of his hemorrhagic stroke in April 2016 were terrible. Martin reports: “ I pretty much went straight into atrophy and spasticity. I could hardly do anything with my right side. My shoulder was subluxed and I wore a Kafo orthosis and a shoulder brace. I hated every minute of my life”.
One of Canada’s top research hospitals, The Ottawa Hospital, has presented results from its 2022 quality improvement study into patient outcomes after spinal surgery when using nasal photodisinfection for the prevention of surgical site infections (‘SSIs’).